[HTML][HTML] Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a …

T Shi, DA McAllister, KL O'Brien, EAF Simoes… - The Lancet, 2017 - thelancet.com
Background We have previously estimated that respiratory syncytial virus (RSV) was
associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) …

After asthma: redefining airways diseases

ID Pavord, R Beasley, A Agusti, GP Anderson, E Bel… - The Lancet, 2018 - thelancet.com
Executive summary Asthma is responsible for considerable global morbidity and health-care
costs. Substantial progress was made against key outcomes such as hospital admissions …

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

NI Mazur, J Terstappen, R Baral, A Bardají… - The Lancet Infectious …, 2023 - thelancet.com
Respiratory syncytial virus is the second most common cause of infant mortality and a major
cause of morbidity and mortality in older adults (aged> 60 years). Efforts to develop a …

Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants

B Kampmann, SA Madhi, I Munjal… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …

[HTML][HTML] Nirsevimab for prevention of RSV in healthy late-preterm and term infants

LL Hammitt, R Dagan, Y Yuan… - … England Journal of …, 2022 - Mass Medical Soc
Background Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract
infection and hospitalization in infants. Nirsevimab is a monoclonal antibody to the RSV …

[HTML][HTML] Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years …

Y Li, X Wang, DM Blau, MT Caballero, DR Feikin… - The Lancet, 2022 - thelancet.com
Background Respiratory syncytial virus (RSV) is the most common cause of acute lower
respiratory infection in young children. We previously estimated that in 2015, 33· 1 million …

Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study

HJ Zar, D Hanslo, P Apolles, G Swingler, G Hussey - The Lancet, 2005 - thelancet.com
Background For microbiological confirmation of diagnosis of pulmonary tuberculosis in
young children, sequential gastric lavages are recommended; sputum induction has not …

Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8.

E DiMango, HJ Zar, R Bryan… - The Journal of clinical …, 1995 - Am Soc Clin Investig
Respiratory epithelial cells play a crucial role in the inflammatory response during
Pseudomonas aeruginosa infection in the lungs of patients with cystic fibrosis. In this study …

Improving lung health in low-income and middle-income countries: from challenges to solutions

J Meghji, K Mortimer, A Agusti, BW Allwood, I Asher… - The Lancet, 2021 - thelancet.com
Low-income and middle-income countries (LMICs) bear a disproportionately high burden of
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …

[HTML][HTML] Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study

MP Nicol, L Workman, W Isaacs, J Munro… - The Lancet infectious …, 2011 - thelancet.com
Background WHO recommends that Xpert MTB/RIF replaces smear microscopy for initial
diagnosis of suspected HIV-associated tuberculosis or multidrug-resistant pulmonary …